Cities Changing Diabetes by Health Innovation Manchester | Novo Nordisk

Cities Changing Diabetes by Health Innovation Manchester | Novo Nordisk

30 May . 1 min read.

Cities Changing Diabetes (CCD) is a partnership programme established to address the global urban diabetes challenge. Initiated in 2014 by Danish pharmaceutical company Novo Nordisk, the programme is a response to the dramatic rise of urban diabetes and has been developed in partnership with University College London and Steno Diabetes Center, Copenhagen.

Cities Changing Diabetes was launched with a clear ambition: to accelerate the global fight against urban diabetes. Working with partner cities, new approaches have been developed to map the challenge, understand the areas of greatest risk and vulnerability and design interventions that can begin to deliver real impact.

Join us on Monday 17 June as Health Innovation Manchester and Novo Nordisk announce the partnership and discuss their shared ambition to bend the curve of type 2 diabetes. Greater Manchester will become the twenty-first city in the programme, joining Copenhagen, Houston, Vancouver, Johannesburg, Mexico City, Rome, Shanghai, Tianjin, Xiamen, Beirut, Buenos Aires, Hangzhou, Jakarta, Koriyama, Madrid, Mérida, Milan and Leicester.

Guests to the launch will hear from local people living with type 2 diabetes, speakers from within the Cities Changing Diabetes network, diabetes specialists working across Greater Manchester and guests from public health organisations in Denmark and Italy, who will discuss how the CCD programme has helped drive change in type 2 diabetes awareness and outcomes.

We use cookies to ensure that we give you the best experience on our website. If you would like to change your preferences you may do so by following the instructions here. More info. That's fine